Dublin, July 28, 2023 (GLOBE NEWSWIRE) -- The "Global Cough Suppressant Drugs Market Forecast, 2023-2030" report has been added to ResearchAndMarkets.com's offering.
The Global Cough Suppressant Drugs Market shows promising growth, estimated at USD 1.98 billion in 2023, projected to expand at a Compound Annual Growth Rate (CAGR) of 4.61% to reach USD 2.72 billion by 2030. However, significant long-term effects are anticipated due to the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation. Ongoing research analyzes changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic and considers the impact of geopolitical uncertainties in Eastern Europe.
Market Dynamics
- Drivers
- Increase in the cases of chronic lung disorders
- Surge in the number of smokers globally
- Emergence in vulnerable indoor as well as outdoor allergens
- Restraints
- Huge cost associated with treatment and shortage of skilled labor
- Opportunities
- Development of novel therapies and drugs
- Government initiatives for advanced healthcare infrastructures
- Challenges
- Side impacts of cough suppressant drugs
Market Segmentation & Coverage
The market is segmented based on Disease Type, Drug Type, Age Group, Dosage Form, Distribution Channel, and Region. Wet Cough leads the market among Disease Types, while Pholcodine is projected to witness significant market share among Drug Types. The Adult segment dominates the Age Group category, and Tablets are expected to hold a substantial market share in Dosage Forms. Among Distribution Channels, Retail Drug Stores are projected to lead the market.
Market Statistics
The report provides market sizing and forecasts in 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF, facilitating well-informed decision-making. Historical data from 2018 to 2021, with 2022 as the base year, 2023 as the estimated year, and the forecast period from 2024 to 2030, are considered in the study.
FPNV Positioning Matrix
The FPNV Positioning Matrix evaluates the Global Cough Suppressant Drugs Market based on key metrics within Business Strategy and Product Satisfaction, enabling informed decision-making by users. Vendors are classified into four distinct quadrants: Forefront (F), Pathfinder (P), Niche (N), or Vital (V), representing varying levels of success.
Market Share Analysis
The Market Share Analysis provides valuable insights into the current state of vendors in the market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, the analysis aids in understanding vendor performance and competitiveness.
Key Pointers Covered in the Report:
- Market Penetration: Comprehensive information on the market offered by key players
- Market Development: In-depth insights into lucrative emerging markets and penetration across mature segments
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments
- Market Trends: Understanding the cumulative impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation on market trends
- Competitive Assessment & Intelligence: Exhaustive evaluation of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments
The report addresses essential questions, such as the market size and forecast, impact of COVID-19 on market dynamics, investment opportunities, competitive strategies, technology trends, market share of leading vendors, and suitable modes for entering the Global Cough Suppressant Drugs Market.
Key Attributes
| Report Attribute | Details |
| No. of Pages | 180 |
| Forecast Period | 2023-2030 |
| Estimated Market Value (USD) in 2023 | $1.98 Billion |
| Forecasted Market Value (USD) by 2030 | $2.72 Billion |
| Compound Annual Growth Rate | 4.6% |
| Regions Covered | Global |
Key Topics Covered
1. Preface
2. Research Methodology
3. Executive Summary
4. Market Overview
5. Market Insights
6. Cough Suppressant Drugs Market, by Disease Type
7. Cough Suppressant Drugs Market, by Drug Type
8. Cough Suppressant Drugs Market, by Age Group
9. Cough Suppressant Drugs Market, by Dosage Form
10. Cough Suppressant Drugs Market, by Distribution Channel
11. Americas Cough Suppressant Drugs Market
12. Asia-Pacific Cough Suppressant Drugs Market
13. Europe, Middle East & Africa Cough Suppressant Drugs Market
14. Competitive Landscape
15. Competitive Portfolio
16. Appendix
Companies Profiled
- Acella Pharmaceuticals, LLC
- Alvizia Healthcare Private Limited
- Amneal Pharmaceuticals, Inc.
- Athens Labs Ltd.
- Aurobindo Pharma Limited
- Aytu BioScience, Inc.
- Bayer AG
- GlaxoSmithKline PLC
- Mayne Pharma, Inc.
- Pfizer Inc.
- Solace Biotech Ltd.
- Taro Pharmaceutical Industries
- Tris Pharma, Inc.
- Vernalis PLC
- Zenes Biotech Pvt. Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/jf7m6k
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
